Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery
新辅助Trebananib联合紫杉醇化疗治疗II/III期乳腺癌:适应性随机I-SPY2试验的疗效和生物标志物发现
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-2256
Albain, Kathy S; Yau, Christina; Petricoin, Emanuel F; Wolf, Denise M; Lang, Julie E; Chien, A Jo; Haddad, Tufia; Forero-Torres, Andres; Wallace, Anne M; Kaplan, Henry; Pusztai, Lajos; Euhus, David; Nanda, Rita; Elias, Anthony D; Clark, Amy S; Godellas, Constantine; Boughey, Judy C; Isaacs, Claudine; Tripathy, Debu; Lu, Janice; Yung, Rachel L; Gallagher, Rosa I; Wulfkuhle, Julia D; Brown-Swigart, Lamorna; Krings, Gregor; Chen, Yunn Yi; Potter, David A; Stringer-Reasor, Erica; Blair, Sarah; Asare, Smita M; Wilson, Amy; Hirst, Gillian L; Singhrao, Ruby; Buxton, Meredith; Clennell, Julia L; Sanil, Ashish; Berry, Scott; Asare, Adam L; Matthews, Jeffrey B; DeMichele, Angela M; Hylton, Nola M; Melisko, Michelle; Perlmutter, Jane; Rugo, Hope S; Symmans, W Fraser; Van't Veer, Laura J; Yee, Douglas; Berry, Donald A; Esserman, Laura J